510(k) · Cardiovascular

Empatica Health Monitoring Platform; EmbracePlus; Empatica Care; Care Portal

by Empatica S.R.L.

Empatica Health Monitoring Platform; EmbracePlus; Empatica Care; Care Portal is an AI-enabled medical device from Empatica S.R.L. that the U.S. FDA cleared through 510(k) K242737 on June 6, 2025. Its lead review panel is Cardiovascular and its primary product code is MWI (Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)).

See also FDA-cleared AI cardiovascular devices in 2025, all FDA AI clearances in 2025, top cardiovascular AI devices.

Key facts

Submission numberK242737
Pathway510(k)
Date of final decision
Company (FDA list)Empatica S.R.L.
Lead review panelCardiovascular
Primary product codeMWI — Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)
Applicant (openFDA)Empatica S.r.l.
Applicant locationMilan, IT
Device classClass 2
Regulation number21 CFR 870.2300
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. Empatica Health Monitoring Platform; EmbracePlus; Empatica Care; Care Portal went through this pathway (K242737).

openFDA lists it as a Class 2 device under 21 CFR 870.2300. Class II devices are moderate risk and are subject to general and special controls.

Product code MWI covers 5 devices on the FDA AI list. By decision date, this device is #5 of 5 under that code. Empatica S.R.L. has 4 AI-enabled devices on the list, and the Cardiovascular panel accounts for 154 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code MWI)

More from Empatica S.R.L.